Shuttle Pharmaceuticals (SHPH) Competitors $4.31 -0.17 (-3.79%) Closing price 04:00 PM EasternExtended Trading$4.44 +0.13 (+3.02%) As of 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SHPH vs. ATNF, DWTX, NERV, CYCC, BFRG, BIVI, PHIO, IXHL, CMMB, and TRAWShould you be buying Shuttle Pharmaceuticals stock or one of its competitors? The main competitors of Shuttle Pharmaceuticals include 180 Life Sciences (ATNF), Dogwood Therapeutics (DWTX), Minerva Neurosciences (NERV), Cyclacel Pharmaceuticals (CYCC), Bullfrog AI (BFRG), BioVie (BIVI), Phio Pharmaceuticals (PHIO), Incannex Healthcare (IXHL), Chemomab Therapeutics (CMMB), and Traws Pharma (TRAW). These companies are all part of the "pharmaceutical products" industry. Shuttle Pharmaceuticals vs. Its Competitors 180 Life Sciences Dogwood Therapeutics Minerva Neurosciences Cyclacel Pharmaceuticals Bullfrog AI BioVie Phio Pharmaceuticals Incannex Healthcare Chemomab Therapeutics Traws Pharma 180 Life Sciences (NASDAQ:ATNF) and Shuttle Pharmaceuticals (NASDAQ:SHPH) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, dividends, earnings, risk, media sentiment, valuation, analyst recommendations and institutional ownership. Which has preferable valuation & earnings, ATNF or SHPH? Shuttle Pharmaceuticals is trading at a lower price-to-earnings ratio than 180 Life Sciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio180 Life SciencesN/AN/A-$6.17M-$15.07-0.17Shuttle PharmaceuticalsN/AN/A-$9.15M-$4.15-1.04 Which has more volatility & risk, ATNF or SHPH? 180 Life Sciences has a beta of 0.38, meaning that its stock price is 62% less volatile than the S&P 500. Comparatively, Shuttle Pharmaceuticals has a beta of -1.01, meaning that its stock price is 201% less volatile than the S&P 500. Do analysts prefer ATNF or SHPH? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score 180 Life Sciences 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00Shuttle Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Do insiders and institutionals hold more shares of ATNF or SHPH? 4.1% of 180 Life Sciences shares are held by institutional investors. Comparatively, 4.6% of Shuttle Pharmaceuticals shares are held by institutional investors. 38.2% of 180 Life Sciences shares are held by insiders. Comparatively, 12.6% of Shuttle Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Is ATNF or SHPH more profitable? 180 Life Sciences' return on equity of -141.25% beat Shuttle Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets 180 Life SciencesN/A -141.25% -80.77% Shuttle Pharmaceuticals N/A -772.76%-347.06% Does the media favor ATNF or SHPH? In the previous week, 180 Life Sciences' average media sentiment score of 0.00 equaled Shuttle Pharmaceuticals'average media sentiment score. Company Overall Sentiment 180 Life Sciences Neutral Shuttle Pharmaceuticals Neutral Summary180 Life Sciences beats Shuttle Pharmaceuticals on 6 of the 8 factors compared between the two stocks. Get Shuttle Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SHPH and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SHPH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SHPH vs. The Competition Export to ExcelMetricShuttle PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.80M$2.62B$6.16B$10.57BDividend YieldN/A53.54%5.50%4.66%P/E Ratio-1.0424.4085.5827.12Price / SalesN/A742.11608.62133.04Price / CashN/A28.3526.3031.10Price / Book0.995.3712.876.67Net Income-$9.15M$32.78M$3.30B$276.23M7 Day Performance13.42%3.90%4.80%3.31%1 Month Performance27.70%9.99%8.11%10.76%1 Year Performance-85.20%-3.12%75.85%33.58% Shuttle Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SHPHShuttle Pharmaceuticals0.4234 of 5 stars$4.31-3.8%N/A-84.6%$4.80MN/A-1.045Positive NewsATNF180 Life SciencesN/A$2.48-1.2%N/A+78.2%$14.98MN/A-0.167DWTXDogwood Therapeutics2.6202 of 5 stars$7.70-2.7%$12.00+55.8%N/A$14.72MN/A-0.415Gap DownNERVMinerva Neurosciences3.1597 of 5 stars$2.10flat$5.00+138.1%-19.2%$14.68MN/A1.429CYCCCyclacel Pharmaceuticals0.165 of 5 stars$6.44-4.9%N/A-97.1%$14.43M$40K-0.0114High Trading VolumeBFRGBullfrog AI0.2964 of 5 stars$1.40+1.4%N/A-46.5%$14.35M$33.26K-1.844BIVIBioVie0.1988 of 5 stars$1.90-0.5%N/A-83.6%$14.31MN/A-0.0210Gap UpPHIOPhio Pharmaceuticals2.1731 of 5 stars$2.48+5.1%$14.00+464.5%-22.4%$14.21MN/A-0.7610Gap DownIXHLIncannex Healthcare0.7787 of 5 stars$0.46-10.5%N/A-70.6%$13.67M$98K-0.383News CoverageShort Interest ↓CMMBChemomab Therapeutics3.1023 of 5 stars$2.63-0.8%$26.50+907.6%-55.0%$13.60MN/A-1.1120High Trading VolumeTRAWTraws Pharma1.0979 of 5 stars$1.85-2.1%N/A-59.3%$13.06M$230K0.0217News CoverageGap Up Related Companies and Tools Related Companies ATNF Alternatives DWTX Alternatives NERV Alternatives CYCC Alternatives BFRG Alternatives BIVI Alternatives PHIO Alternatives IXHL Alternatives CMMB Alternatives TRAW Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SHPH) was last updated on 10/6/2025 by MarketBeat.com Staff From Our PartnersGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredTrump Devises the Death of the IRS ☠️Trump has just signed an executive order creating America's first-ever National Investment Fund — a game-chang...Angel Publishing | SponsoredU.S. Government Sparking Crypto RallySecond Chances Don't Come Often in Crypto My "Crypto Bull Run Millionaire Blueprint" reveals everything - w...Crypto 101 Media | SponsoredGet my No. 1 gold stock nowGold recently broke past $3,800 per ounce – setting yet another new all-time high. And Wall Street banks sa...Stansberry Research | SponsoredThe $20 stock that could make silicon chips obsolete$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredOctober 2025 Market Crash?Wall Street Legend Names #1 Stock [not NVDA] The greatest quantitative mind on Wall Street just revealed hi...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Shuttle Pharmaceuticals Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Shuttle Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
